AKT1 and polycystic ovary syndrome: Specifically, Its activation of either the PDE-cAMP-AMPK-SIRT1 axis and the PI3K-Akt signaling pathway highlights novel therapeutic strategies for addressing IR and glucose metabolism disturbances in PCOS.